This Ab has also been seen to act against tissue inflammation and remodeling in a murine model of chronic experimental asthma [63], demonstrating that a specific targeting of CD300a in CCR3-positive cells may be a potent tool for treating airway inflammation and tissue remodeling [63]. Here, CD300A is linked to asthma.